Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching

See also
Status	Clinical Trial	Phase
Completed	`NCT05038982` - Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin	Phase 2
Completed	`NCT04510090` - Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus	Phase 1
Not yet recruiting	`NCT05500794` - Meditation in Inflammatory Dermatosis	N/A
Completed	`NCT02143973` - Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Completed	`NCT01236859` - Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus	N/A
Completed	`NCT00782054` - Evaluation of Post Burn Rehabilitation Population for Itch Control	Phase 4
Completed	`NCT04999787` - A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus	Phase 2
Recruiting	`NCT04256759` - Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus	Phase 2
Completed	`NCT04337073` - The Effect of Propofol on Dexamethasone-induced Perineal Pruritus	Early Phase 1
Completed	`NCT04415034` - Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis
Recruiting	`NCT05525520` - Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis	Phase 2
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT04399525` - Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.	N/A
Recruiting	`NCT02432508` - Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis	N/A
Completed	`NCT02653703` - L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain	N/A
Completed	`NCT01963793` - Topical Aprepitant in Prurigo Patients	Phase 2
Completed	`NCT01232985` - Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults	Phase 2
Not yet recruiting	`NCT00577967` - Gabapentin - A Solution to Uremic Pruritus?	N/A
Recruiting	`NCT06120907` - Swiss Itch Registry
Recruiting	`NCT04589429` - Adding Nalbuphine for Control of Intrathecal Morphine Pruritus	Phase 2

NCT number	NCT01825655
Study type	Interventional
Source	Virginia Commonwealth University
Contact
Status	Terminated
Phase	Phase 4
Start date	September 2014
Completion date	November 2017

Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms